Close

IKT Financial Facts

See Full Income Statement

See Full Balance Sheet

Inhibikase Therapeutics (IKT) Earnings

  |   Expand Research on IKT
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -12.5% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -2.1% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/14/23 Q323 -$0.86-$0.87 +$0.01N/AN/A N/A Details
8/14/23 Q223 -$1.11-$0.81 -$0.30N/AN/A N/A Details
5/15/23 Q123 -$0.16-$0.14 -$0.02$64.52KN/A N/A Details
3/31/23 Q422 N/A-$0.19 N/A N/AN/A N/A N/A N/A
11/14/22 Q322 N/A-$0.18 N/A N/A$200K N/A N/A N/A
8/12/22 Q222 N/A-$0.19 N/A N/A$300K N/A N/A N/A
5/16/22 Q122 N/A-$0.17 N/A N/A$300K N/A N/A N/A
4/1/22 Q421 N/A-$0.17 N/A N/A$300K N/A N/A N/A